# Spatial Regulation of Endocytosis and Adhesion Formation Governs Breast Cancer Cell Migration Under Confinement

**Authors:** Emily T. Chan, Travis H. Jones, Cristopher M. Thompson, Hariharan Kannan, Malcolm W. D’Souza, Mushtaq M. Ali, Cömert Kural, Jonathan W. Song

PMC · DOI: 10.3390/bioengineering12111148 · 2025-10-23

## TL;DR

This study shows how endocytosis and adhesion control breast cancer cell movement in tight spaces, offering new insights into cancer metastasis.

## Contribution

A novel microfluidic platform enables spatially controlled drug delivery to study endocytosis and adhesion in confined cell migration.

## Key findings

- Front-targeted endocytic inhibition increased cell migration speed without affecting persistence.
- Rear-targeted endocytic inhibition disrupted paxillin and AP-2 polarity but did not change migration speed.
- Endocytic polarity regulates adhesion dynamics during confined migration of breast cancer cells.

## Abstract

Cell migration through confined spaces is a critical step in cancer metastasis, yet the spatial regulation of endocytosis and adhesion dynamics during this process remains poorly understood. To investigate this, we adapted a microfluidic platform that generates stable, spatially linear biochemical gradients across 5 μm-tall migration channels. COMSOL simulations and optical calibration using FITC-dextran confirmed that gradients form reliably within 5 min. The microdevice also supports long-term live imaging and is compatible with both spinning disk confocal and total internal reflection fluorescence structured illumination microscopy modalities, enabling high-resolution visualization of adhesion and endocytic structures. By leveraging this platform for spatially restricted drug delivery, we locally applied the endocytic inhibitor Dyngo-4a to either the front or rear of migrating cells. This revealed that front-targeted endocytic inhibition preserved or increased leading-edge enrichment of paxillin and the clathrin adaptor AP-2, whereas rear-targeted inhibition eliminated paxillin polarity and reduced AP-2 polarity. These changes were accompanied by a significant increase in cell migration speed under front-targeted inhibition, while rear-targeted inhibition had no significant effect on speed and neither treatment altered persistence. Together, these findings suggest that endocytic polarity regulates adhesion dynamics and cell migration under confinement, offering a mechanistic insight into processes relevant to cancer cell invasion.

## Linked entities

- **Proteins:** LOC575064 (leupaxin), FABP4 (fatty acid binding protein 4)
- **Chemicals:** Dyngo-4a (PubChem CID 136227923)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** PXN (paxillin) [NCBI Gene 5829], TFAP2A (transcription factor AP-2 alpha) [NCBI Gene 7020] {aka AP-2, AP-2alpha, AP2TF, BOFS, TFAP2}
- **Diseases:** metastasis (MESH:D009362), Breast Cancer (MESH:D001943), cancer (MESH:D009369)
- **Chemicals:** FITC-dextran (MESH:C015219)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649363/full.md

---
Source: https://tomesphere.com/paper/PMC12649363